Consistently, EEER administration to BPH-1 cells inhibited cell viability, which was accompanied by reduced levels of the phosphorylated ERK1/2 protein, as well as PCNA and cyclin D1 (Figure 3B), indicating that EEER repressed the growth of BPH-1 cells. This evidence concerns the gene CCND1 and benign prostatic hyperplasia.